Attempting to address these inconsistencies, Wu et al. [29] conducted a meta-analysis of 11 studies (n = 897; 529 PCOS and 368 controls) and found that MCP-1/CCL2 levels were significantly elevated in those with PCOS compared to non-PCOS populations. This evidence concerns the gene CCL2 and polycystic ovary syndrome.